Researcher profile

Alexander Chervov

Alexander Chervov contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Computational challenges of cell cycle analysis using single cell transcriptomics

The cell cycle is one of the most fundamental biological processes important for understanding normal physiology and various pathologies such as cancer. Single cell RNA sequencing technologies give an opportunity to analyse the cell cycle transcriptome dynamics in an unprecedented range of conditions (cell types and perturbations), with thousands of publicly available datasets. Here we review the main computational tasks in such analysis: 1) identification of cell cycle phases, 2) pseudotime inference, 3) identification and profiling of cell cycle-related genes, 4) removing cell cycle effect, 5) identification and analysis of the G0 (quiescent) cells. We review seventeen software packages that are available today for the cell cycle analysis using scRNA-seq data. Despite huge progress achieved, none of the packages can produce complete and reliable results with respect to all aforementioned tasks. One of the major difficulties for existing packages is distinguishing between two patterns of cell cycle transcriptomic dynamics: normal and characteristic for embryonic stem cells (ESC), with the latter one shared by many cancer cell lines. Moreover, some cell lines are characterized by a mixture of two subpopulations, one following the standard and one ESC-like cell cycle, which makes the analysis even more challenging. In conclusion, we discuss the difficulties of the analysis of cell cycle-related single cell transcriptome and provide certain guidelines for the use of the existing methods.

preprint2020arXiv

Trajectories, bifurcations and pseudotime in large clinical datasets: applications to myocardial infarction and diabetes data

Large observational clinical datasets become increasingly available for mining associations between various disease traits and administered therapy. These datasets can be considered as representations of the landscape of all possible disease conditions, in which a concrete pathology develops through a number of stereotypical routes, characterized by `points of no return' and `final states' (such as lethal or recovery states). Extracting this information directly from the data remains challenging, especially in the case of synchronic (with a short-term follow up) observations. Here we suggest a semi-supervised methodology for the analysis of large clinical datasets, characterized by mixed data types and missing values, through modeling the geometrical data structure as a bouquet of bifurcating clinical trajectories. The methodology is based on application of elastic principal graphs which can address simultaneously the tasks of dimensionality reduction, data visualization, clustering, feature selection and quantifying the geodesic distances (pseudotime) in partially ordered sequences of observations. The methodology allows positioning a patient on a particular clinical trajectory (pathological scenario) and characterizing the degree of progression along it with a qualitative estimate of the uncertainty of the prognosis. Overall, our pseudo-time quantification-based approach gives a possibility to apply the methods developed for dynamical disease phenotyping and illness trajectory analysis (diachronic data analysis) to synchronic observational data. We developed a tool $ClinTrajan$ for clinical trajectory analysis implemented in Python programming language. We test the methodology in two large publicly available datasets: myocardial infarction complications and readmission of diabetic patients data.